Rani Therapeutics
OverviewSuggest Edit
Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company is based in San Jose, California.
| Type | Private | |
| Founded | 2012 | |
| HQ | San Jose, US | Map |
| Website | ranitherapeutics.com |
Key People/Management at Rani Therapeutics
Mir Hashim
Vice President, Research & Development
Bob Gaffney
Vice President, Operations
Syed Zaidi
Vice President, Finance
Mike Billig
Vice President, Regulatory, Quality & Clinical
Joel Harris
Sr. Director of Intellectual Property
Rani Therapeutics Office Locations
Rani Therapeutics has an office in San Jose
San Jose, US (HQ)
2051 Ringwood Ave
Rani Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Rani Therapeutics total Funding | $107.5 m |
Rani Therapeutics latest funding size | $53 m |
Time since last funding | 2 years ago |
Rani Therapeutics investors | Novartis, InCube Ventures, AstraZeneca, Shire, Western Life Sciences Venture Fund LP, VentureHealth, The Stevanato Group, Crystal Horizon Investments, Pinemount Investment, Pacific Venture Opportunity Fund, GV, Ping An Ventures, Buttonwood Capital, Virtus Inspire Ventures, Cathay Venture, GeneScience Pharmaceuticals, Bossa Ventures |
Rani Therapeutics's latest funding round in February 2018 was reported to be $53 m. In total, Rani Therapeutics has raised $107.5 m
Rani Therapeutics Online and Social Media Presence
Rani Therapeutics's Trends
Rani Therapeutics News and Updates
May 10, 2019
Rani Therapeutics Hires First CFO
SAN JOSE, Calif., May 10, 2019 /PRNewswire/ -- Rani Therapeutics, creator of the robotic RaniPill™ capsule designed to replace injections of large drug molecules including peptides, proteins, and antibodies, today announced that Svai Sanford has joined the company as its first Chief...
February 08, 2018
Rani Therapeutics hauls in $53 mln
Rani Therapeutics, a developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, has raised $53 million in funding. The investors included GeneScience Pharmaceuticals, Bossa Ventures, Cathay Venture Inc, GV, Alphabet Inc's investment arm, Novartis, …
Rani Therapeutics Blogs
September 10, 2019
Inventor Mir Imran: “I’d like to see the art of innovation taught in K-12. If we teach everyone to innovate, everyone will be an innovator, regardless of their profession.”
The post Inventor Mir Imran: “I’d like to see the art of innovation taught in K-12. If we teach everyone to innovate, everyone will be an innovator, regardless of their profession.” appeared first on Rani Therapeutics.
Rani Therapeutics Frequently Asked Questions
When was Rani Therapeutics founded?
Rani Therapeutics was founded in 2012.
Who are Rani Therapeutics key executives?
Rani Therapeutics's key executives are Mir Hashim, Bob Gaffney and Syed Zaidi.
Who are Rani Therapeutics competitors?
Competitors of Rani Therapeutics include Principia BioPharma, Oramed Pharmaceuticals and Athersys.
Where is Rani Therapeutics headquarters?
Rani Therapeutics headquarters is located at 2051 Ringwood Ave, San Jose.
Where are Rani Therapeutics offices?
Rani Therapeutics has an office in San Jose.
How many offices does Rani Therapeutics have?
Rani Therapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies